COVID-19 and diabetes mellitus: Public health problem in Mexico
COVID-19 and diabetes mellitus: Public health problem in Mexico
DOI:
https://doi.org/10.59420/remus.6.2021.4Keywords:
Diabetes mellitus, public health, COVID-19Abstract
Diabetes mellitus has been established as a public health issue due to its rising prevalence and the possible complications it can cause. COVID-19 has represented a challenge for the actions of the healthcare system, mainly in question of the prevention measures and population control. A bibliographic review was carried out with the objective of describing the problems that have arisen in the Mexican public health system as a consequence of the interaction between COVID-19 and diabetes mellitus. Different studies have shown the increased risk of severe complications and mortality in patients with both diseases. In addition, the lack of access to necessary drugs, non[1]attendance of medical consultation, misinformation and the psychosocial aspects are factors that have affected the health in patients with diabetes mellitus. We conclude that more studies of comprehensive care and glycemic control in diabetic patients with COVID-19 are needed.
Downloads
References
Hernández-Ávila M, Gutiérrez JP, Reynoso-Noverón N. Diabetes mellitus en México. El estado de la epidemia. Salud Publica Mex 2013;55 supl 2:S129-S136.
Carrillo-Larco R, Bernabé-Ortiz A. Diabetes mellitus tipo 2 en Perú: una revisión sistemática sobre la prevalencia e incidencia en población general. Revista Peruana de Medicina Experimental y Salud Pública. 2019;36(1):26.
American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2020. Diabetes Care. 2019;43(Supplement 1):S14- S31.
DeFronzo R, Ferrannini E, Groop L, Henry R, Herman W, Holst J et al. Type 2 diabetes mellitus. Nature Reviews Disease Primers. 2015;1(1).
International Diabetes Federation. IDF Diabetes Atlas, 9th edn. Brussels, Belgium: 2019. Available at: https://www.diabetesatlas.org
Chamberlain J, Rhinehart A, Shaefer C, Neuman A. Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes. Annals of Internal Medicine. 2016;164(8):542.
Mayer-Davis EJ, Lawrence JM, Dabelea D, et al. Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012. N Engl J Med 2017; 376:1419.
Dabelea D, Mayer-Davis EJ, Saydah S, et al. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA 2014; 311:1778.
Dabelea D, Pihoker C, Talton JW, et al. Etiological approach to characterization of diabetes type: the SEARCH for Diabetes in Youth Study. Diabetes Care 2011; 34:1628
Mayer-Davis EJ, Kahkoska AR, Jefferies C, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes 2018; 19 Suppl 27:7.
Harjutsalo V, Sund R, Knip M, Groop PH. Incidence of type 1 diabetes in Finland. JAMA 2013; 310:427.
Wacher N, Gómez-Díaz R, Ascencio-Montiel I, Rascón-Pacheco R, Aguilar-Salinas C, Borja-Aburto V. Type 1 diabetes incidence in children and adolescents in Mexico: Data from a nation-wide institutional register during 2000–2018. Diabetes Research and Clinical Practice. 2020;159:107949.
Writing Group for the SEARCH for Diabetes in Youth Study Group, Dabelea D, Bell RA, et al. Incidence of diabetes in youth in the United States. JAMA 2007; 297:2716.
Anık A, Çatlı G, Abacı A, Böber E. Maturity-onset diabetes of the young (MODY): an update. Journal of Pediatric Endocrinology and Metabolism. 2015;28(3-4).
Cameron F, Wherrett D. Care of diabetes in children and adolescents: controversies, changes, and consensus. Lancet. 2015; 385 (9982): 2096-2106.
Rangel-Coronado R, Chávez García T, Mendoza-Zubieta V, Ferreira-Hermosillo A. Diabetes del adulto de inicio juvenil: reporte de un caso. Rev Med Inst Mex Seguro Soc. 2019; 57(4): 252-8
Lim S, Bae J, Kwon H, Nauck M. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nature Reviews Endocrinology. 2020;17(1):11-30.
Abrams E, Szefler S. COVID-19 and the impact of social determinants of health. The Lancet Respiratory Medicine. 2020;8(7):659-661
Wu Z, McGoogan J. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA. 2020;323(13):1239
Schmulson M, Dávalos MF, Berumen J. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19. Rev Gastroenterol Mex. 2020 Jul - Sep;85(3):282-7.
Singh S, Pritam M, Pandey B, Yadav T. Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review. Journal of Medical Virology. 2020;93(1):275- 299.
Apicella M, Campopiano M, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. The Lancet Diabetes & Endocrinology. 2020;8(9):782-792.
WHO Coronavirus (COVID-19) Dashboard [Internet]. Covid19.who.int. 2021 [cited 09 April 2021]. Available from: https://covid19.who.int/
Lazcano-Ponce E, Alpuche-Aranda C. Alfabetización en salud pública ante la emergencia de la pandemia por Covid-19. Salud Pública de México. 2020;62(3, may-jun):331.
Lazcano-Ponce E, Alpuche-Aranda Rojas-Martínez R, Basto-Abreu A, Aguilar-Salinas CA, Zárate-Rojas E, Villalpando S, Barrientos Gutiérrez T. Prevalencia de diabetes por diagnóstico médico previo en México. Salud Publica Mex 2018;60:224-232.
Secretaría de Salud. Encuesta Nacional de Salud 2018. México: Secretaría de Salud, 2018 [citado mayo 6, 2021]. Disponible en: https://ensanut.insp.mx/encuestas/ensanut2018/doctos/informes/ensanut_2018_presentacion_resultados.pdf
Pal R, Bhadada S. COVID-19 and diabetes mellitus: An unholy interaction of two pandemics. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14(4):513-517.
Hussain A, Bhowmik B, do Vale Moreira NC. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract. 2020 Apr;162:108142.
Bergman M, Jagannathan R, Narayan KMV. Nexus of COVID-19 and diabetes pandemics: Global public health lessons. Diabetes Res Clin Pract. 2020 Jun;164:108215.
Pesantes MA, Lazo-Porras M, Cardenas MK, Diez-Canseco F, Zafra-Tanaka JH, Carrillo-Larco RM, Bernabé-Ortiz A, Málaga G, Miranda JJ. Los retos del cuidado de las personas con diabetes durante el estado de emergencia nacional por la COVID-19 en Lima, Perú: recomendaciones para la atención primaria. Rev Peru Med Exp Salud Publica. 2020;37(3):541- 6. doi: https://doi.org/10.17843/rpmesp.2020.373.5980.
Cuschieri S, Grech S. COVID-19 and diabetes: The why, the what and the how. J Diabetes Complications. 2020 Sep;34(9):107637. doi: 10.1016/j.jdiacomp.2020.107637. Epub 2020 May 22. PMID: 324568F46; PMCID: PMC7242955.
Álvarez-López DI, Espinoza-Molina MP, Cruz-Loustaunau ID, Álvarez-Hernández G. La diabetes e hipertensión arterial como factores asociados con la letalidad por Covid-19 en Sonora, México, 2020. Salud Publica Mex [Internet]. 29 de agosto de 2020 [citado 21 de mayo de 2021];62(5, sep-oct):456- 7. Disponible en: https://www.saludpublica.mx/index.php/spm/article/view/11546
Denova-Gutiérrez E, Lopez-Gatell H, Alomia-Zegarra JL, López-Ridaura R, Zaragoza-Jimenez CA, Dyer-Leal DD, et al. The Association of Obesity, Type 2 Diabetes, and Hypertension with Severe Coronavirus Disease 2019 on Admission Among Mexican Patients. Obesity (Silver Spring). 2020 10;28(10):1826-32
Klatman EL, Besançon S, Bahendeka S, Mayige M, Ogle GD. COVID-19 and type 1 diabetes: Challenges and actions. Diabetes Res Clin Pract. 2020 08;166:108275.
Acosta LD. Capacidad de respuesta frente a la pandemia de COVID-19 en América Latina y el Caribe. Rev Panam Salud Publica. 2020;44:e109. https://doi.org/10.26633/RPSP.2020.109
Andrikopoulos S, Johnson G. The Australian response to the COVID-19 pandemic and diabetes - Lessons learned. Diabetes Res Clin Pract. 2020 Jul;165:108246.
Barrientos-Gutiérrez T, Alpuche-Aranda C, Lazcano-Ponce E, Pérez Ferrer C, Rivera-Dommarco J. La salud pública en la primera ola: una agenda para la cooperación ante Covid-19. Salud Publica Mex. 2020;62:598-606. https://doi.org/10.21149/11606
Barrientos-Gutiérrez T, Alpuche-Aranda C, Lazcano-Ponce E, Pérez Ferrer C, Rivera-Dommarco J. La salud pública en la primera ola: una agenda para la cooperación ante Covid-19. Salud Publica Mex. 2020;62:598-606. https://doi.org/10.21149/11606
Millán-Guerrero R, Caballero-Hoyos R, Monárrez-Espino J. Poverty and survival from COVID-19 in Mexico. Journal of Public Health. 2020
Pablos-Méndez A, Vega J, Aranguren FP et al. Covid-19 in Latin America. Responses are complicated by poverty, comorbidity, and political dynamics. BMJ 2020;370:m2939
Fountoulakis KN, Fountoulakis NK, Koupidis SK et al. Factors determining different death rates because of the COVID-19 outbreak among countries. J Public Health 2020;fdaa119.
Rodríguez-Quiroga A, Buiza C, Mon MAÁ, Quintero J. [Update on COVID-19 and mental health]. Medicine (Madr). 2020 Dec;13(23):1285-96.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 REMUS - Revista Estudiantil de Medicina de la Universidad de Sonora
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
